Microsatellite Stable Colorectal Cancer Epidemiology Report 2022: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan 2019-2032 - ResearchAndMarkets.com

·3 min read

DUBLIN, January 25, 2022--(BUSINESS WIRE)--The "Microsatellite Stable Colorectal Cancer - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.

The Microsatellite Stable Colorectal Cancer epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Microsatellite Stable Colorectal Cancer epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM.

The Microsatellite Stable Colorectal Cancer epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

  • The Microsatellite Stable Colorectal Cancer report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

  • The Microsatellite Stable Colorectal Cancer Epidemiology Report and Model provide an overview of the global trends of Microsatellite Stable Colorectal Cancer in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)

  • The report provides insight into the historical and forecasted patient pool of Microsatellite Stable Colorectal Cancer in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan

  • The report helps recognize the growth opportunities in the 7MM for the patient population

  • The report assesses the disease risk and burden and highlights the unmet needs of Microsatellite Stable Colorectal Cancer

  • The report provides the segmentation of the Microsatellite Stable Colorectal Cancer epidemiology

Report Highlights

  • 11-year Forecast of Microsatellite Stable Colorectal Cancer epidemiology

  • 7MM Coverage

  • Prevalent and Diagnosed Cases of Microsatellite Stable Colorectal Cancer

  • Cases of Microsatellite Stable Colorectal Cancer by Mutation Types

  • Microsatellite Stable Colorectal Cancer Cases associated with Clinical Manifestations

Key Assessments

  • Patient Segmentation

  • Disease Risk & Burden

  • Risk of disease by the segmentation

  • Factors driving growth in a specific patient population

Key Topics Covered:

1. Key Insights

2. Executive Summary of Microsatellite Stable Colorectal Cancer

3. Microsatellite Stable Colorectal Cancer: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Microsatellite Stable Colorectal Cancer Epidemiology Scenario in the 7MM (2019-2032)

5.4. United States Epidemiology

5.4.1. Microsatellite Stable Colorectal Cancer Epidemiology Scenario in the United States (2019-2032)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Microsatellite Stable Colorectal Cancer Epidemiology Scenario in Germany (2019-2032)

5.5.2. France Epidemiology

5.5.2.1. Microsatellite Stable Colorectal Cancer Epidemiology Scenario in France (2019-2032)

5.5.3. Italy Epidemiology

5.5.3.1. Microsatellite Stable Colorectal Cancer Epidemiology Scenario in Italy (2019-2032)

5.5.4. Spain Epidemiology

5.5.4.1. Microsatellite Stable Colorectal Cancer Epidemiology Scenario in Spain (2019-2032)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Microsatellite Stable Colorectal Cancer Epidemiology Scenario in the United Kingdom (2019-2032)

5.6. Japan Epidemiology

5.6.1. Microsatellite Stable Colorectal Cancer Epidemiology Scenario in Japan (2019-2032)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Microsatellite Stable Colorectal Cancer Treatment and Management

6.2. Microsatellite Stable Colorectal Cancer Treatment Algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/wrts85

View source version on businesswire.com: https://www.businesswire.com/news/home/20220125005930/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900